Reduced morbidity following cytoreductive surgery and intraperitoneal hyperthermic chemoperfusion

Annals of Surgical Oncology

Volumn 11, Issue 4, 2004, Pages 387-392

  Ahmad, Syed A ^a   Kim, Joseph ^a   Sussman, Jeffrey J ^a   Soldano, Debbie A ^a   Pennington, Linda J ^a   James, Laura E ^a   Lowy, Andrew M ^a  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

Appendiceal carcinoma; Cytoreduction; Hyperthermia; Intraperitoneal chemotherapy; Peritoneal carcinomatosis

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; MITOMYCIN C; ANTINEOPLASTIC AGENT;

ADULT; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER SURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOREDUCTIVE SURGERY; DIGESTIVE SYSTEM CANCER; FEMALE; GASTROINTESTINAL SURGERY; GYNECOLOGIC SURGERY; HOSPITALIZATION; HUMAN; HYPERTHERMIC INTRAPERITONEAL CHEMOTHERAPY; HYPERTHERMIC THERAPY; LENGTH OF STAY; MALE; MINIMAL RESIDUAL DISEASE; MORBIDITY; OVARY CARCINOMA; PERIOPERATIVE PERIOD; PERITONECTOMY; PERITONEUM; PERITONEUM CANCER; POSTOPERATIVE COMPLICATION; POSTOPERATIVE PERIOD; SURGEON; SURGICAL MORTALITY; SURGICAL TECHNIQUE; TECHNIQUE; TREATMENT OUTCOME; APPENDIX TUMOR; CARCINOMA; INFUSION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PERITONEUM TUMOR; PROGNOSIS; SURVIVAL RATE;

ADULT; AGED; ANTINEOPLASTIC AGENTS; APPENDICEAL NEOPLASMS; CARCINOMA; COMBINED MODALITY THERAPY; FEMALE; HUMANS; HYPERTHERMIA, INDUCED; INFUSIONS, PARENTERAL; MALE; MIDDLE AGED; PERITONEAL NEOPLASMS; PERITONEUM; PROGNOSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 3142723285     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1245/ASO.2004.09.007     Document Type: Article

References (24)

1. Sugarbaker PH, Schellinx MET, Chang D, Koslowe P, von Meyerfeldt M. Peritoneal carcinomatosis from adenocarcinoma of the colon. World J Surg 1996;20:585-92.
2. Witkamp AJ, de Bree E, Kaag MM, et al. Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin. Eur J Cancer 2001;37:979-84.
3. Loggie BW, Fleming RA, McQuellon RP, Russell GB, Geisinger KR. Cytoreductive surgery with intraperitoneal hyperthermic chemotherapy for disseminated peritoneal cancer of gastrointestinal origin. Am Surg 2000;66:561-8.
4. Sugarbaker PH. Intraperitoneal chemotherapy and cytoreductive surgery for the prevention and treatment of peritoneal carcinomatosis and sarcomatosis. Seminin Surg Oncol 1998;14:254-61.
5. Ceelen WP, Hesse U, de Hemptinne B, Pattyn P. Hyperthermic intraperitoneal chemoperfusion in the treatment of locally advanced intra-abdominal cancer. Br J Surg 2000;87:1006-15.
6. Sugarbaker PH, Zhu BW, Sese GB, Shmookler B. Peritoneal carcinomatosis from appendiceal cancer: results in 69 patients treated by cytoreductive surgery and intraperitoneal chemotherapy. Dis Colon Rectum 1993;36:323-9.
7. Yonemura Y, Fujimora T, Fushida S, et al. Hyperthermo-chemotherapy combined with cytoreductive surgery for the treatment of gastric cancer with peritoneal dissemination. World J Surg 1991; 15:530-6.
8. Sugarbaker PH, Chang D. Results of treatment of 385 patients with peritoneal surface spread of appendiceal malignancy. Ann Surg Oncol 1999;6:727-31.
9. Esquivel J, Sugarbaker PH. Clinical presentation of the pseudomyxoma peritonei syndrome. Br J Surg 2000;87:1414-8.
10. Esquivel J, Vidal-Jove J, Steves MA, Sugarbaker PH. Morbidity and mortality of cytoreductive surgery and intraperitoneal chemotherapy. Surgery 1993;113:631-6.
11. Butterworth SA, Panton ONM, Klaassen DJ, Shah AM, McCregor GI. Morbidity and mortality associated with intraperitoneal chemotherapy for pseudomyxoma peritonei. Am J Surg 2002;183: 529-32.
12. Stephens AD, Alderman R, Chang D, et al. Morbidity and mortality analysis of 200 treatments with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy using the open technique. Ann Surg Oncol 1999;6:790-6.
13. Culliford AT, Brooks AD, Sharma S, et al. Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer. Ann Surg Oncol 2001;8:787-95.
14. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden F, Zoetmulder FAN. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88:458-63.
15. Verwaal VJ, Ruth SV, de Bree E, Slooten GWV, Tinteren VH, Boot H, Zoetmulder FAN. Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer. J Clin Oncol 2003;21:3737-43.
16. Sugarbaker PH. Peritonectomy procedures. Ann Surg 1995;221: 29-42.
17. Spratt JS, Adcock RA, Muskovin M, Sherrill W, McKeown J. Clinical delivery system for intraperitoneal hyperthermic chemotherapy. Can Res 1980;40:256-60.
18. Fumagalli U, Trabucchi E, Soligo M, et al. Effects of intraperitoneal chemotherapy on anastomotic healing in the rat. J Surg Res 1991;50:82-7.
19. Esquivel J, Angulo F, Bland RK, Stephens AD, Sugarbaker PH. Hemodynamic and cardiac function parameters during heated intraperitoneal chemotherapy using the open "open technique". Ann Surg Oncol 2000;7:296-300.
20. Stuart OA, Stephens AD, Welch L, Sugarbaker PH. Safety monitoring of the open technique for heated intraperitoneal chemotherapy with mitomycin C. Ann Surg Oncol 2002;9:186-91.
21. Jacquet P, Stephens AD, Averbach AM, et al. Analysis of morbidity and mortality in 60 patients with peritoneal carcinomatosis treated by cytoreductive surgery and heated intraperitoneal chemotherapy. Cancer 1996;77:2622-9.
22. Sugarbaker PH. Pseudomyxoma peritonei syndrome. Adv Surg 1997;30:233-80.
23. Cavaliere F, Perri P, Di Filippo F, et al. Treatment of peritoneal carcinomatosis with intent to cure. J Surg Oncol 2000;74:41-4.
24. Witkamp AJ, de Bree E, Kaag MM, van Slooten GW, van Coevorden, Zoetmulder FAN. Extensive surgical cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in patients with pseudomyxoma peritonei. Br J Surg 2001;88: 459-63.